// App-Quantinova.ai

1420 : Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)

Researchers

Presenter

  • Denis Mongin

Principal Investigators

  • Denis Choquette

  • Catalin Codreanu

  • Ori Elkayam

  • Kimme Hyrich

  • Florenzo Iannone

  • Eirik Kristianslund

  • Tore Kvien

  • Burkhard Leeb

  • Galina Lukina

  • Dan Nordstrom

  • Fatos Onen

  • Karel Pavelka

  • Manuel Pombo-Suarez

  • Ziga Rotar

  • Maria Jose Santos

  • Anja Strangfeld

  • Delphine Courvoisier

  • Axel Finckh

Medical Centers

  • Division of Rheumatology, Geneva University Hospital, Switzerland / Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, Geneva, Switzerland

  • Division of Rheumatology, Geneva University Hospital, Switzerland, Geneva, Switzerland

  • Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands

  • Institut de Recherche en Rhumatologie de Montréal, University of Montreal, Québec, Canada., Montreal, QC, Canada

  • Center of Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania., Bucharest, Romania

  • Rheumatology, Tel-Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom / NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, United Kingdom

  • Department of Emergency and Transplantation , Rheumatology Unit, University Hospital of Bari, Bari, Italy., Bari, Italy

  • Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

  • Diakonhjemmet Hospital, Dept. of Rheumatology / University of Oslo, Faculty of Medicine, Oslo, Norway

  • Second Department of Medicine, Centre for Rheumatology Lower Austria, State Hospital Stockerau, Stockerau, Austria., Stockerau, Austria

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

  • Department of Medicine, ROB-FIN, Helsinki University Hospital and Helsinki University, Helsinki, Finland., Helsinki, Finland

  • Dokuz Eylul University School of Medicine, Division of Rheumatology, Ä°zmir, Turkey

  • Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2, Czech Republic

  • Rheumatology Service , Hospital Clinico Universitario , Santiago de Compostela , Spain., Santiago de Compostela, Spain

  • UMC LJUBLJANA, DPT. OF RHEUMATOLOGY, LJUBLJANA, Slovenia

  • Pediatric, Hospital Garcia de Orta EPE, Almada, Portugal

  • German Rheumatism Research Centre, Berlin, Germany

  • Division of Rheumatology, Geneva University Hospital, Switzerland, Geneva, Switzerland

Locations

  • Switzerland

  • Netherlands

  • Canada

  • Romania

  • Israel

  • United Kingdom

  • Italy

  • Norway

  • Austria

  • Russia

  • Finland

  • Turkey

  • Czech Republic

  • Spain

  • Slovenia

  • Portugal

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Baricitinib

  • Tasocitinib

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved